Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennewein

Showing results (261-270 of 301) with videos related to

Pageof 31
Sort By:
NPJ Vaccines|November 3, 2022
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stabilityEmily A Voigt, Alana Gerhardt, Derek Hanson, et al.
Plos Pathogens|June 3, 2016
Correction: Antigen-Specific Antibody Glycosylation Is Regulated via VaccinationAlison E Mahan, Madeleine F Jennewein, Todd Suscovich, et al.
Plos Pathogens|March 17, 2016
Antigen-Specific Antibody Glycosylation Is Regulated via VaccinationAlison E Mahan, Madeleine F Jennewein, Todd Suscovich, et al.
The Biochemical Journal|December 3, 2011
Allosteric antibody inhibition of human hepsin proteaseTobias Koschubs, Stefan Dengl, Harald Dürr, et al.
Cell|June 18, 2019
Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected WomenDavid R Martinez, Youyi Fong, Shuk Hang Li, et al.
BMC Health Services Research|November 30, 2019
Communication and patient safety in gynecology and obstetrics - study protocol of an intervention studySonia Lippke, Julian Wienert, Franziska Maria Keller, et al.
Oncotarget|October 6, 2017
Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose fluxElena I Ilina, Angela Armento, Leticia Garea Sanchez, et al.
Frontiers in Immunology|May 14, 2025
A bivalent self-amplifying RNA vaccine against yellow fever and Zika virusesPeter Battisti, Matthew R Ykema, Darshan N Kasal, et al.
Communications Biology|April 12, 2022
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunitNicholas K Hurlburt, Leah J Homad, Irika Sinha, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 22, 2025
An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunityWynton D McClary, Devin S Brandt, Madeleine F Jennewein, et al.
Pageof 31

Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
NPJ Vaccines|November 3, 2022
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stabilityEmily A Voigt, Alana Gerhardt, Derek Hanson, et al.
Plos Pathogens|June 3, 2016
Correction: Antigen-Specific Antibody Glycosylation Is Regulated via VaccinationAlison E Mahan, Madeleine F Jennewein, Todd Suscovich, et al.
Plos Pathogens|March 17, 2016
Antigen-Specific Antibody Glycosylation Is Regulated via VaccinationAlison E Mahan, Madeleine F Jennewein, Todd Suscovich, et al.
The Biochemical Journal|December 3, 2011
Allosteric antibody inhibition of human hepsin proteaseTobias Koschubs, Stefan Dengl, Harald Dürr, et al.
Cell|June 18, 2019
Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected WomenDavid R Martinez, Youyi Fong, Shuk Hang Li, et al.
BMC Health Services Research|November 30, 2019
Communication and patient safety in gynecology and obstetrics - study protocol of an intervention studySonia Lippke, Julian Wienert, Franziska Maria Keller, et al.
Oncotarget|October 6, 2017
Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose fluxElena I Ilina, Angela Armento, Leticia Garea Sanchez, et al.
Frontiers in Immunology|May 14, 2025
A bivalent self-amplifying RNA vaccine against yellow fever and Zika virusesPeter Battisti, Matthew R Ykema, Darshan N Kasal, et al.
Communications Biology|April 12, 2022
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunitNicholas K Hurlburt, Leah J Homad, Irika Sinha, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 22, 2025
An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunityWynton D McClary, Devin S Brandt, Madeleine F Jennewein, et al.
Pageof 31